Pain News and Research

Latest Pain News and Research

TikoMed, BRI partner to investigate IBsolvMIR in phase II trial for chronic pancreatitis

Baylor Research Institute (BRI), the research arm of Baylor Health Care System, and TikoMed AB announced today that an agreement has been established to investigate TikoMed´s product IBsolvMIR® in a phase II clinical trial.

28 Feb 2013

Combined spinal-epidural technique offers faster and better-quality analgesia during early labor

During the first stage of labor, a combined spinal-epidural (CSE) technique offers faster and better-quality analgesia (pain relief) compared to traditional epidural analgesia, according to a report in the March issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

28 Feb 2013

Radiation, surgery offer best survival possibilities for metastatic gastric cancer patients

Researchers at Moffitt Cancer Center studied patients with metastatic gastric cancer and found that those who have both surgery and radiation have better survival than those who receive one or no form of treatment.

28 Feb 2013

Double-jointed teens at risk for later pain

Adolescents who have hypermobile joints or are “double jointed” are more likely to develop moderate to severe joint pain in later years, show study findings.

28 Feb 2013

Fatigue before cancer treatment impacts fatigue afterwards

Individuals who survive cancer are significantly more likely to develop severe persistent fatigue a year after treatment if they were fatigued before and shortly after treatment, indicate Dutch study findings.

28 Feb 2013

Orofacial treatment beneficial for headache plus temporomandibular disorder

Patients with features of cervicogenic headache who also show signs of temporomandibular disorder may benefit from receiving orofacial treatment in addition to usual cervical manual therapy care, say researchers in Manual Therapy.

28 Feb 2013

Hypermobile children at greater risk for joint pain as they get older

A prospective study by U.K. researchers found that adolescents who are double-jointed—medically termed joint hypermobility—are at greater risk for developing musculoskeletal pain as they get older, particularly in the shoulders, knees, ankles and feet. Findings published in Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR), indicate that children with joint hypermobility are approximately twice as likely to develop pain at these joints.

28 Feb 2013

FSMB announces recipients of 2013 medical awards

The Federation of State Medical Boards (FSMB) announced the recipients of its 2013 awards recognizing outstanding service and leadership in the field of medical regulation.

28 Feb 2013

EpiCept fourth quarter revenue decreases to $0.1 million

EpiCept Corporation today announced operating and financial results for the fourth quarter and full year ended December 31, 2012, and provided an update on the Company's merger with Immune Pharmaceuticals, Ltd. (Immune).

28 Feb 2013

Adolescents with joint hypermobility more likely to develop musculoskeletal pain

A prospective study by U.K. researchers found that adolescents who are double-jointed-medically termed joint hypermobility-are at greater risk for developing musculoskeletal pain as they get older, particularly in the shoulders, knees, ankles and feet.

28 Feb 2013

Scientists identify two populations of human cells that migrate to the intestine

Researchers at Wake Forest Baptist Medical Center and colleagues have identified a special population of adult stem cells in bone marrow that have the natural ability to migrate to the intestine and produce intestinal cells, suggesting their potential to restore healthy tissue in patients with inflammatory bowel disease (IBD).

28 Feb 2013

Anesthetics during breast cancer surgery may affect development of chronic pain

In women with breast cancer, the choice of anesthetic used for mastectomy may affect the risk of developing long-term pain after surgery, according to a study in the March issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

28 Feb 2013

Primary care practices discriminating on socioeconomic status

An audit of family physician and general practitioner offices in Canada reveals that patients with lower incomes are subject to discrimination when trying to access primary care.

27 Feb 2013

Ampio Pharmaceuticals starts Optina clinical trial

Ampio Pharmaceuticals, Inc. announced oral dosing of the first patient in a 505(b)(2) clinical trial of the investigational drug Optina in diabetic macular edema.

27 Feb 2013

Study shows people of high socioeconomic status more likely to get access to primary care

People of high socioeconomic status are more likely to be able to access primary care than those of low socioeconomic status, even within a universal health care system in which physicians are reimbursed equally for each patient, found an article published in CMAJ.

27 Feb 2013

Offices of family physicians appear to give preference to people with chronic health conditions

Some family physicians' offices discriminate against people of low socio-economic status, even when there is no economic incentive to do so under Canada's system of publicly funded universal health insurance, new research has shown.

27 Feb 2013

New journal aims to address fatigue in medical illnesses and specific environmental conditions

With peer-reviewed articles on fatigue having increased 90% over the past decade - and nearly 1,000 papers on the topic published in 2011 alone - the time is right for Routledge's new journal, Fatigue: Biomedicine, Health & Behavior.

27 Feb 2013

Baxter files FEIBA NF BLA with FDA for prophylactic treatment of hemophilia A or B

Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) supplement to the U.S. Food and Drug Administration (FDA) for the approval of prophylaxis treatment of FEIBA NF [Anti-Inhibitor Coagulant Complex], Nanofiltered and Vapor Heated, in patients with hemophilia A or B and inhibitors.

From Baxter International Inc. 26 Feb 2013

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom of vulvar and vaginal atrophy due to menopause.

26 Feb 2013

Learned helplessness role in inflammatory polyarthritis revealed

Learned helplessness is a modifiable risk factor that can significantly influence disease outcome in patients with inflammatory polyarthritis, UK clinicians believe.

26 Feb 2013

Pain News and Research

Latest Pain News and Research

TikoMed, BRI partner to investigate IBsolvMIR in phase II trial for chronic pancreatitis

Combined spinal-epidural technique offers faster and better-quality analgesia during early labor

Radiation, surgery offer best survival possibilities for metastatic gastric cancer patients

Double-jointed teens at risk for later pain

Fatigue before cancer treatment impacts fatigue afterwards

Orofacial treatment beneficial for headache plus temporomandibular disorder

Hypermobile children at greater risk for joint pain as they get older

FSMB announces recipients of 2013 medical awards

EpiCept fourth quarter revenue decreases to $0.1 million

Adolescents with joint hypermobility more likely to develop musculoskeletal pain

Scientists identify two populations of human cells that migrate to the intestine

Anesthetics during breast cancer surgery may affect development of chronic pain

Primary care practices discriminating on socioeconomic status

Ampio Pharmaceuticals starts Optina clinical trial

Study shows people of high socioeconomic status more likely to get access to primary care

Offices of family physicians appear to give preference to people with chronic health conditions

New journal aims to address fatigue in medical illnesses and specific environmental conditions

Baxter files FEIBA NF BLA with FDA for prophylactic treatment of hemophilia A or B

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

Learned helplessness role in inflammatory polyarthritis revealed

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Pain News and Research

Latest Pain News and Research

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Newsletters you may be interested in